Non-Hodgkin Lymphoma /Features
Innovative Medicines Initiative approves €40 million HARMONY project for better care of patients with hematologic malignancies
The Innovative Medicines Initiative (IMI) has approved HARMONY, a project that aims to foster better access and care for patients…
Acute Myeloid Leukemia
Chronic Lymphocytic Leukemia
Multiple Myeloma
Myelodysplastic Syndromes
Non-Hodgkin Lymphoma
1 year
Solving the CARD11 puzzle and gaining a deeper understanding of oncogenic mutations
CARD11 is a scaffold protein that is critical for antigen receptor signaling. Normally, it is locked in an “off” position…
Non-Hodgkin Lymphoma
2 years
